280 related articles for article (PubMed ID: 17278887)
1. Epithelial ovarian cancer and low malignant potential (LMP) tumors associated with a lower incidence of second primary breast cancer.
Hunter MI; Ziogas A; Flores F; Brewster WR
Am J Clin Oncol; 2007 Feb; 30(1):1-7. PubMed ID: 17278887
[TBL] [Abstract][Full Text] [Related]
2. Increased risk of second cancer among patients with ovarian borderline tumors.
Bouchardy C; Fernandez S; Merglen A; Usel M; Fioretta G; Rapiti E; Schubert H; Pelte MF; Chappuis PO; Vlastos G
Gynecol Oncol; 2008 May; 109(2):210-4. PubMed ID: 18377966
[TBL] [Abstract][Full Text] [Related]
3. Second lymphomas and other malignant neoplasms in patients with mycosis fungoides and Sezary syndrome: evidence from population-based and clinical cohorts.
Huang KP; Weinstock MA; Clarke CA; McMillan A; Hoppe RT; Kim YH
Arch Dermatol; 2007 Jan; 143(1):45-50. PubMed ID: 17224541
[TBL] [Abstract][Full Text] [Related]
4. Increased risk for second primary malignancies in women with breast cancer diagnosed at young age: a population-based study in Taiwan.
Lee KD; Chen SC; Chan CH; Lu CH; Chen CC; Lin JT; Chen MF; Huang SH; Yeh CM; Chen MC
Cancer Epidemiol Biomarkers Prev; 2008 Oct; 17(10):2647-55. PubMed ID: 18843006
[TBL] [Abstract][Full Text] [Related]
5. Breast cancer risk factors and second primary malignancies among women with breast cancer.
Trentham-Dietz A; Newcomb PA; Nichols HB; Hampton JM
Breast Cancer Res Treat; 2007 Oct; 105(2):195-207. PubMed ID: 17186360
[TBL] [Abstract][Full Text] [Related]
6. Second neoplasms after invasive and borderline ovarian cancer.
Levi F; Randimbison L; Blanc-Moya R; La Vecchia C
Eur J Cancer Prev; 2009 Jun; 18(3):216-9. PubMed ID: 19491608
[TBL] [Abstract][Full Text] [Related]
7. Outcomes of women with metachronous breast and ovarian carcinomas.
Liou WS; Hamilton CA; Cheung MK; Osann K; Longacre TA; Teng NN; Husain A; Dirbas FM; Chan JK
Gynecol Oncol; 2006 Oct; 103(1):190-4. PubMed ID: 16569424
[TBL] [Abstract][Full Text] [Related]
8. Survival among women with borderline ovarian tumors and ovarian carcinoma: a population-based analysis.
Sherman ME; Mink PJ; Curtis R; Cote TR; Brooks S; Hartge P; Devesa S
Cancer; 2004 Mar; 100(5):1045-52. PubMed ID: 14983501
[TBL] [Abstract][Full Text] [Related]
9. Second primary ovarian cancer among women diagnosed previously with cancer.
Hall HI; Jamison P; Weir HK
Cancer Epidemiol Biomarkers Prev; 2001 Sep; 10(9):995-9. PubMed ID: 11535553
[TBL] [Abstract][Full Text] [Related]
10. Primary malignancy after primary female breast cancer in the South of the Netherlands, 1972-2001.
Soerjomataram I; Louwman WJ; de Vries E; Lemmens VE; Klokman WJ; Coebergh JW
Breast Cancer Res Treat; 2005 Sep; 93(1):91-5. PubMed ID: 16184464
[TBL] [Abstract][Full Text] [Related]
11. Ovarian cancer incidence in the United States, 1992-1999.
Quirk JT; Natarajan N
Gynecol Oncol; 2005 May; 97(2):519-23. PubMed ID: 15863154
[TBL] [Abstract][Full Text] [Related]
12. Nonbreast second malignancies after treatment of primary breast cancer.
Yadav BS; Sharma SC; Patel FD; Ghoshal S; Kapoor R; Kumar R
Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1489-92. PubMed ID: 18804919
[TBL] [Abstract][Full Text] [Related]
13. Incidence of second cancer within 5 years of diagnosis of a breast, prostate or colorectal cancer: a population-based study.
Cluze C; Delafosse P; Seigneurin A; Colonna M
Eur J Cancer Prev; 2009 Sep; 18(5):343-8. PubMed ID: 19436213
[TBL] [Abstract][Full Text] [Related]
14. [Bilateral breast cancer. Incidence and risk factors].
El Hanchi Z; Berrada R; Fadli A; Ferhati D; Brahmi R; Baydada A; Kharbach A; Chaoui A
Gynecol Obstet Fertil; 2004 Feb; 32(2):128-34. PubMed ID: 15123135
[TBL] [Abstract][Full Text] [Related]
15. Risk of second malignancies in survivors of retinoblastoma: more than 40 years of follow-up.
Marees T; Moll AC; Imhof SM; de Boer MR; Ringens PJ; van Leeuwen FE
J Natl Cancer Inst; 2008 Dec; 100(24):1771-9. PubMed ID: 19066271
[TBL] [Abstract][Full Text] [Related]
16. Multiple primary tumors involving cancer of the brain and central nervous system as the first or subsequent cancer.
Inskip PD
Cancer; 2003 Aug; 98(3):562-70. PubMed ID: 12879474
[TBL] [Abstract][Full Text] [Related]
17. Second malignant neoplasms among long-term survivors of ovarian cancer.
Travis LB; Curtis RE; Boice JD; Platz CE; Hankey BF; Fraumeni JF
Cancer Res; 1996 Apr; 56(7):1564-70. PubMed ID: 8603403
[TBL] [Abstract][Full Text] [Related]
18. Incidences and trends of second cancers in female breast cancer patients: a fixed inception cohort-based analysis (United States).
Yu GP; Schantz SP; Neugut AI; Zhang ZF
Cancer Causes Control; 2006 May; 17(4):411-20. PubMed ID: 16596293
[TBL] [Abstract][Full Text] [Related]
19. Patients with a history of epithelial ovarian cancer presenting with a breast and/or axillary mass.
Karam AK; Stempel M; Barakat RR; Morrow M; Gemignani ML
Gynecol Oncol; 2009 Mar; 112(3):490-5. PubMed ID: 19101713
[TBL] [Abstract][Full Text] [Related]
20. Secondary cancers after a lung carcinoid primary: a population-based analysis.
Cote ML; Wenzlaff AS; Philip PA; Schwartz AG
Lung Cancer; 2006 Jun; 52(3):273-9. PubMed ID: 16567020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
